Emerson Electric Co.
—- Market cap
- $84.87B
- Debt
- +$13.12B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 87% equity / 13% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: EMR stock price at premium vs EXPE $152.15 current versus $113.07 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EXPE's multiple
Implied fair value · at EMR's multiple
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EMR FY 2025 (ended Sep 30, 2025) · EXPE FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 87% equity / 13% debt
Capital structure 80% equity / 20% debt · EV / Revenue 2.28x · EV / EBITDA 9.77x
EMR carries the larger enterprise value at $97.99B against $33.55B; EXPE trades on the lower EV / Revenue multiple (2.28x vs 5.44x); EXPE on the lower EV / EBITDA (9.77x vs 21.31x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EMERSON ELECTRIC CO. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
EXPEDIA GROUP, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.65x
6.12x
Net debt / EBITDA
Leverage against operating earnings
—
0.62x
Cash and equivalents
Liquid reserves on the balance sheet
—
$5.73B
Total debt
Interest-bearing obligations outstanding
$13.12B
$7.85B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.